Kenneth Kehn-Yao Poon

Kenneth Kehn-Yao Poon

Auto-generated profile, based on publicly available information

Kenneth Kehn-Yao Poon

Division of Infectious Disease, Memorial Healthcare System , Pembroke Pines, Florida , USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 May 2024 in BJS Open
Verified
Journal Article
Open access
PDF file
Kumar JayantKumar Jayant
Kumar Jayant
IRIsabella Reccia
Isabella Reccia
ACAdriano Carneiro
Adriano Carneiro
MPMauro Podda
Mauro Podda
FVFrancesco Virdis
Francesco Virdis
OLOmar Llaguna
Omar Llaguna
Pancreatoduodenectomy is associated with an increased incidence of surgical-site infections, often leading to a significant rise in morbidity and mortality. This trend underlines the inadequacy of traditional antibiotic prophylaxis strategies. Hence, the aim of this meta-analysis was to assess the outcomes of antimicrobial prophylaxis, comparing piperacillin/tazobactam with traditional antibiotics. Upon registering in PROSPERO, the international prospective register of systematic reviews (CRD42023479100), a systematic search of various databases was conducted over the interval 2000–2023. This inclusive search encompassed a wide range of study types, including prospective and retrospective cohorts and RCTs. The subsequent data analysis was carried out utilizing RevMan 5.4. A total of eight studies involving 2382 patients who underwent pancreatoduodenectomy and received either piperacillin/tazobactam (1196 patients) or traditional antibiotics (1186 patients) as antibiotic prophylaxis during surgery were included in the meta-analysis. Patients in the piperacillin/tazobactam group had significantly reduced incidences of surgical-site infections (OR 0.43 (95% c.i. 0.30 to 0.62); P < 0.00001) and major surgical complications (Clavien–Dindo grade greater than or equal to III) (OR 0.61 (95% c.i. 0.45 to 0.81); P = 0.0008). Subgroup analysis of surgical-site infections highlighted significantly reduced incidences of superficial surgical-site infections (OR 0.34 (95% c.i. 0.14 to 0.84); P = 0.02) and organ/space surgical-site infections (OR 0.47 (95% c.i. 0.28 to 0.78); P = 0.004) in the piperacillin/tazobactam group. Further, the analysis demonstrated significantly lower incidences of clinically relevant postoperative pancreatic fistulas (grades B and C) (OR 0.67 (95% c.i. 0.53 to 0.83); P = 0.0003) and mortality (OR 0.51 (95% c.i. 0.28 to 0.91); P = 0.02) in the piperacillin/tazobactam group. Piperacillin/tazobactam as antimicrobial prophylaxis significantly lowers the risk of postoperative surgical-site infections, major surgical complications (complications classified as Clavien–Dindo grade greater than or equal to III), clinically relevant postoperative pancreatic fistulas (grades B and C), and mortality, hence supporting the implementation of piperacillin/tazobactam for surgical prophylaxis in current practice.

1 January 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
GBGeorandy B. Bernard
Georandy B. Bernard
SMSheila Montalvo
Sheila Montalvo
SIStipe Ivancic
Stipe Ivancic
PEPaula Eckardt
Paula Eckardt
KPKenneth Kehn-Yao Poon
Kenneth Kehn-Yao Poon
DADiana C. Andrade
Diana C. Andrade

14 June 2022 in Journal of the American Pharmacists Association
Verified
Journal Article
Closed access
GBGeorandy B. Bernard
Georandy B. Bernard
SMSheila Montalvo
Sheila Montalvo
SIStipe Ivancic
Stipe Ivancic
PEPaula Eckardt
Paula Eckardt
KPKenneth Kehn-Yao Poon
Kenneth Kehn-Yao Poon
DADiana C. Andrade
Diana C. Andrade